About Us: Partnership Opportunities

With our proprietary approach, Allarity Therapeutics is at the forefront of cancer precision medicine development.

Our DRP® platform is able to unlock the complexity of a tumor and provide a best-in-class companion diagnostic to match the right patient to the right cancer drug.
Allarity Therapeutics seeks partnering opportunities in the following areas:
  • Co-development and co-funding of Phase 2 and Phase 3 clinical trials
  • Creation of joint ventures to advance programs of mutual interest
  • Regional or global drug development and marketing programs
  • DRP® companion diagnostic development for external drug program

Interested in partnering opportunities with Allarity? Contact us at
[email protected]